Page 1,955«..1020..1,9541,9551,9561,957..1,9601,970..»

Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid …

Posted: October 30, 2014 at 1:40 pm

Chicago, Illinois (PRWEB) October 30, 2014

On October 26th at the Mid American Regenerative and Cellular Medicine Showcase in Chicago, leading applied stem cell research scientist Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna presented talks on New Techniques for Enhancing Stem Cell Therapy Effectiveness and Orthopedic Surgical Applications For Stem Cells.

Dr. Riordan focused on historical medical uses of amniotic membrane and the properties of AlphaGEMS that include: wound healing; inflammation and pain reduction; fibrosis risk reduction; growth factor source; adhesion reduction; regeneration support and stem cell enhancement, specifically regarding the mesenchymal stem cells contained within BMAC.

Dr. McKenna discussed the latest applications of BMAC stem cells in orthopedic surgeries like anterior cruciate ligament (ACL) reconstruction and how BMAC injections can virtually eliminate infection risk, reduce complications, increase graft strength, reduce post-surgical inflammation and significantly reduce recovery time. Dr. McKenna also talked about how bone marrow can now be safely and relatively painlessly harvested using his patented BioMAC catheter under local, not general anesthesia.

Dr. Riordan and Dr. McKenna are co-founders of the Riordan-McKenna Institute (RMI), which will be opening soon in Southlake, Texas. RMI will specialize in regenerative orthopedics including non-surgical stem cell therapy and stem cell-enhanced surgery using bone marrow aspirate concentrate (BMAC) and AlphaGEMS amniotic tissue product.

Other noteworthy speakers in attendance included: Paolo Macchiarini, MD-PhD, Arnold Caplan, PhD and Mark Holterman, MD-PhD. Dr. Macchiarini and Dr. Holterman are well known for their work on the first stem cell trachea transplant. Dr. Caplan discovered the mesenchymal stem cell and is commonly referred to as the father of the mesenchymal stem cell.

About Neil Riordan PhD

Dr. Riordan is the co-founder of the Riordan-McKenna Institute (RMI), which will be opening soon in Southlake, Texas. RMI will specialize in regenerative orthopedics including non-surgical stem cell therapy and stem cell-enhanced surgery using bone marrow aspirate concentrate (BMAC) and AlphaGEMS amniotic tissue product.

Dr. Riordan is founder and chief scientific officer of Amniotic Therapies Inc. (ATI). ATI specializes in amniotic tissue research and development. Its current product line includes AlphaGEMS and AlphaPATCH amniotic tissue-based products.

Dr. Riordan is the founder and chairman of Medistem Panama, Inc., (MPI) a leading stem cell laboratory and research facility located in the Technology Park at the prestigious City of Knowledge in Panama City, Panama. Founded in 2007, MPI stands at the forefront of applied research on adult stem cells for several chronic diseases. MPI's stem cell laboratory is ISO 9001 certified and fully licensed by the Panamanian Ministry of Health. Dr. Riordan is the founder of Stem Cell Institute (SCI) in Panama City, Panama (est. 2007).

Read more here:
Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid ...

Posted in Stem Cell Therapy | Comments Off on Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid …

Human Stomach Made in the Lab Using Stem Cells

Posted: October 30, 2014 at 8:51 am

Using pluripotent stem cells researchers have been able to build a mini stomach in the lab.REUTERS

In a first, a miniature stomach was created in the lab by scientists using stem cells.

Pluripotent stem cells that can grow into any cell type were used by scientists at Cincinnati Children's Hospital Medical Center to generate the artificial stomach.

The scientists identified the steps in stomach formation in the human embryo and by manipulating these in a petri dishwere able to coax the stem cells to form a mini stomachmeasuring 3 mm in diameter.

They then studied how h.pylori bacteria affected stomach tissues and spread rapidly. The bacteria is responsible for peptic ulcer and stomach cancer.

This first-time molecular generation of a 3D human stomach (called gastric organoid) presents new opportunities for drug discovery, modelling early stages of stomach cancer and studying some of the underpinnings of obesity related diabetes, according to Jim Wells, PhD, principal investigator and a scientist in the divisions of Developmental Biology and Endocrinology at Cincinnati Children's.

The work was conducted in collaboration with researchers at the University of Cincinnati College of Medicine.

The discovery of how to promote formation of three-dimensional gastric tissue with complex architecture and cellular composition is important as mouse models are sometimes not the best fit when studying human ailments, the team said.

The human gastric organoids will be useful to identify biochemical processes in the gut that allow gastric-bypass patients to become diabetes-free soon after surgery before losing significant weight.

Obesity fuelled diabetes and metabolic syndrome are public health challenges, addressing which has been difficult due to lack of reliable laboratory modelling systems.

See the rest here:
Human Stomach Made in the Lab Using Stem Cells

Posted in Stem Cells | Comments Off on Human Stomach Made in the Lab Using Stem Cells

Beyond the Dish | A developmental biologist muses about …

Posted: October 30, 2014 at 8:45 am

Researchers at Wake Forest Baptist Medical Centers Institute for Regenerative Medicine have hit upon a new strategy for tissue healing: mobilizing the bodys stem cells to the site of injury. Thus harnessing the bodys natural healing powers might make in body regeneration of muscle tissue is a possibility.

Sang Jin Lee, assistant professor of Medicine at Wake Forest, and his colleagues implanted small bits of biomaterial scaffolds into the legs of rats and mice. When they embedded these scaffolds with proteins that mobilize muscle stem cells (like insulin-like growth factor-1 or IGF-1), the stem cells migrated from the muscles to the bioscaffolds and formed muscle tissue.

Working to leverage the bodys own regenerative properties, we designed a muscle-specific scaffolding system that can actively participate in functional tissue regeneration, said Lee. This is a proof-of-concept study that we hope can one day be applied to human patients.

If patients have large sections of muscle removed because of infections, tumors or accidents, muscle grafts from other parts of the body are typically used to restore at least some of the missing muscle. Several laboratories are trying the grow muscle in the laboratory from muscle biopsies that can be then transplanted back into the patient. Growing muscle on scaffolds fashioned from biomaterials have also proven successful.

Lees technique overcomes some of the short-comings of these aforementioned procedures. As Lee put it, Our aim was to bypass the challenges of both of these techniques and to demonstrate the mobilization of muscle cells to a target-specific site for muscle regeneration.

Most tissues in our bodies contain a resident stem cell population that serves to regenerate the tissue as needed. Lee and his colleagues wanted to determine if these resident stem cells could be coaxed to move from the tissue or origin, muscle in this case, and embeds themselves in an implanted scaffold.

In their first experiments, Lee and his team implanted scaffolds into the leg muscles of rats. After retrieving them several weeks later, it was clear that the muscle stem cell population (muscle satellite cells) not only migrated into the scaffold, but other stem cell populations had also taken up residence in the scaffolds. These scaffolds were also contained an interspersed network of blood vessels only 4 weeks aster transplantation.

In their next experiments, Lee and others laced the scaffolds with different cocktails of proteins to boost the stem cell recruitment properties of the implanted scaffolds. The protein that showed the most robust stem cell recruitment ability was IGF-1. In fact, IGF-1-laced scaffolds had four times the number of cells as plain scaffolds and increased formation of muscle fibers.

The protein [IGF-1] effectively promoted cell recruitment and accelerated muscle regeneration, said Lee.

For their next project, Lee would like to test the ability of his scaffolds to promote muscle regeneration in larger laboratory animals.

Continued here:
Beyond the Dish | A developmental biologist muses about ...

Posted in Cell Medicine | Comments Off on Beyond the Dish | A developmental biologist muses about …

Mechanism that allows differentiated cell to reactivate as a stem cell revealed

Posted: October 30, 2014 at 8:45 am

One kind of stem cell, those referred to as 'facultative', form part -- together with other cells -- of tissues and organs. There is apparently nothing that differentiates these cells from the others. However, they have a very special characteristic, namely they retain the capacity to become stem cells again. This phenomenon is something that happens in the liver, an organ that hosts cells that stimulate tissue growth, thus allowing the regeneration of the organ in the case of a transplant. Knowledge of the underlying mechanism that allows these cells to retain this capacity is a key issue in regenerative medicine.

Headed by Jordi Casanova, research professor at the Instituto de Biologa Molecular de Barcelona (IBMB) of the CSIC and at IRB Barcelona, and by Xavier Franch-Marro, CSIC tenured scientist at the Instituto de Biologa Evolutiva (CSIC-UPF), a study published in the journal Cell Reports reveals a mechanism that could explain this capacity. Working with larval tracheal cells of Drosophila melanogaster, these authors report that the key feature of these cells is that they have not entered the endocycle, a modified cell cycle through which a cell reproduces its genome several times without dividing.

"The function of endocycle in living organisms is not fully understood," comments Xavier Franch-Marro. "One of the theories is that endoreplication contributes to enlarge the cell and confers the production of high amounts of protein." This is the case of almost all larval cells of Drosophila.

The scientists have observed that the cells that enter the endocycle lose the capacity to reactivate as stem cells. "The endocycle is linked to an irreversible change of gene expression in the cell," explains Jordi Casanova, "We have seen that inhibition of endocycle entry confers the cells the capacity to reactivate as stem cells."

Cell entry into the endocycle is associated with the expression of the Fzr gene. The researchers have found that inhibition of this gene prevents this entry, which in turn leads to the conversion of the cell into an adult progenitor that retains the capacity to reactivate as a stem cell. Therefore, this gene acts as a switch that determines whether a cell will enter mitosis (the normal division of a cell) or the endocycle, the latter triggering a totally different genetic program with a distinct outcome regarding the capacity of a cell to reactivate as a stem cell.

Story Source:

The above story is based on materials provided by Institute for Research in Biomedicine (IRB Barcelona). Note: Materials may be edited for content and length.

Continued here:
Mechanism that allows differentiated cell to reactivate as a stem cell revealed

Posted in Cell Medicine | Comments Off on Mechanism that allows differentiated cell to reactivate as a stem cell revealed

Grace Centurys Stem Cell Biobank Project Announces Chairmans Appointment to National Stem Cell Ethics Committee of …

Posted: October 30, 2014 at 8:44 am

Ras Al Khaimah, UAE (PRWEB) October 30, 2014

Grace Century portfolio project, Provia Laboratories, announced the appointment of Dr. James A. Manganello, Chairman of the Board, to the National Stem Cell Ethics Committee (NSCEC) of The Bahamas. The appointment was made by the Ministry of Health on behalf of the Government of The Bahamas on September 24th, 2014.

More than a year after Bahamian Parliament passed the Stem Cell Therapy and Research Bill, Prime Minister Perry Christie said the government has completed the accompanying regulations and expects to begin approving applications for stem cell centers this month. Dr. Gomez, Minister of Health, said that the regulation of the stem cell therapy industry will lessen the potential for abuse and will ensure the highest standards of research and treatments are adhered to. Three committees have been established; the National Stem Cell Ethics Committee (NSCEC), the Scientific Committee, and the Compliance Committee.

I am truly honored and delighted to be appointed to the NSCEC, and look forward to being part of the Bahamian Stem Cell Research and Therapy undertaking, said Dr. James Manganello. As Provia continues to expand its reach outside the US, I feel it is important to share our experience and expertise to strengthen the legal and ethical infrastructure for stem cell therapeutics around the world. Participating in committees such as the NSCEC, we can have impact in helping to accelerate this important medical field.

The NSCEC will issue guidelines and approve or deny proposals for stem cell research and therapy. The Compliance Committee will be responsible for ensuring that all stem cell and research guidelines are adhered to. The Scientific Committee will review recommendations from local scientific boards regarding proposed protocols for stem cell research in categories designated by the NSCEC. Gomez said, once the committees become operational, The Bahamas will be one of the first nations with the necessary professional environment, and can potentially lead the world in this new arena that is fascinating while utilizing new technologies, creativity and innovations.

Scott Wolf, CEO of Grace Century also commented, To have Provias Chairman recognized for such a position reflects the firms commitment to excellence.

###

About Provia Laboratories, LLC Provia Laboratories, LLC (http://www.provialabs.com) is a health services company specializing in high quality biobanking (the collection, transport, processing, and cryogenic storage of biological specimens). Its dental stem cell banking service, Store-A-ToothTM, gives parents the option to store stem cells today to protect their childrens health tomorrow. Store-A-Tooth preserves stem cells from baby and wisdom teeth that would otherwise be discarded, so parents can be prepared for advances in stem cell therapies that someday may help treat conditions such as type 1 diabetes, spinal cord injury, heart attack, stroke, and neurological disorders like Parkinsons and Alzheimers. For more information about Store-A-Tooth dental stem cell banking visit: http://www.store-a-tooth.com or http://www.facebook.com/storeatooth.

About Grace Century FZ LLC Grace Century FZ LLC is an International research and private equity consultancy located in Ras Al Khaimah (north of Dubai) in the United Arab Emirates (UAE). Grace Century specializes in game-changing life science and health related private equity projects. For more information, visit http://www.gracecentury.com.

Follow this link:
Grace Centurys Stem Cell Biobank Project Announces Chairmans Appointment to National Stem Cell Ethics Committee of ...

Posted in Cell Therapy | Comments Off on Grace Centurys Stem Cell Biobank Project Announces Chairmans Appointment to National Stem Cell Ethics Committee of …

Scientists generate human stomach tissue using stem cells

Posted: October 29, 2014 at 7:46 pm

CINCINNATI, Oct. 29 (UPI) -- The race to treat and cure the vast range of diseases affecting the human stomach, from cancer to diabetes, has received a boost, thanks to researchers at Cincinnati Children's. In a study published this week in the journal Nature, scientists say they were able to successfully construct miniature human stomachs using stem cells.

Lab-built organs, researchers say, can help medical researchers better observe organ-specific malfunctions and potentially test remedies with more predictive and reliable results. The mini stomachs, created in the Cincinnati lab, are the first examples of three-dimensional human stomach tissue created from pluripotent stem cells -- stem cells that can be programmed to form any type of human cell.

"Until this study, no one had generated gastric cells from human pluripotent stem cells (hPSCs)," lead researcher Jim Wells said in a press release. "In addition, we discovered how to promote formation of three-dimensional gastric tissue with complex architecture and cellular composition."

The key to building any type of organ tissue from stem cells, is understanding the formation of the organ in the embryonic stage of natural human development. Once properly understood, the process can be replicated by manipulating stem cells in a petri dish. And that's exactly what scientists were recently able to do, coaxing pluripotent stem cells into transforming into stomach tissue.

Researchers have already used the mini stomachs to absorb the behavior of H. pylori bacteria, which causes stomach inflammation and can lead to peptic ulcer disease and stomach cancer.

2014 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.

Go here to read the rest:
Scientists generate human stomach tissue using stem cells

Posted in Stem Cells | Comments Off on Scientists generate human stomach tissue using stem cells

Mini human 'stomachs' created from stem cells

Posted: October 29, 2014 at 7:46 pm

Miniature human stomachs have been created from stem cells which could be used to study gastric diseases and develop new treatments in future.

The 3mm-wide hollow "organoids" have a complex 3D structure and are lined with various kinds of functioning cells mimicking those of a real stomach.

In tests, scientists used the tiny stomachs to study infection by Helicobacter pylori, the bacteria linked to peptic ulcers and stomach cancer.

The organoids potentially offer a better way to study human stomach diseases and drug treatments than animals, whose gut physiology is unlike that of humans.

Lead researcher Dr James Wells, from Cincinnati Children's Hospital Medical Center in the US, said: "The breakthrough that we've achieved is we can now generate fully in a petri dish stomach tissue.

"This is important because in the case of people with stomach disease like peptic ulcer disease, or ultimately people who get stomach cancer, we can now study the very early stages of that disease, and then use this as a research tool to try and identify therapies to prevent stomach disease.

"Up until now there's been no good way to study stomach diseases in humans. Human stomach is very different than the stomach of other animals.

"The different cells and their structure and arrangement in our stomach tissues in a dish were virtually identical to that which you would find in a stomach normally."

It may even be possible to generate tissue for plugging holes in the stomach caused by disease, he said.

The organoids were created from human "pluripotent" stem cells, typically originating from early-stage embryos, which have the ability to develop into virtually any kind of tissue.

See original here:
Mini human 'stomachs' created from stem cells

Posted in Stem Cells | Comments Off on Mini human 'stomachs' created from stem cells

Scientists grow miniature human stomachs from stem cells

Posted: October 29, 2014 at 7:46 pm

A CT scan of a human abdomen with stomach cancer. Photograph: Bojan Fatur/Getty Images

Scientists have grown miniature human stomachs from stem cells as a way of studying gastric diseases such as ulcers and stomach cancer and in the future creating tissue to repair patients stomachs.

The mini-stomachs are grown in petri dishes from stem cells. Fully formed, they are the size of a pea and shaped like a rugby ball. They are hollow with an interior lining that is folded into glands and pits like a real stomach.

Crucially, the researchers found that the miniature stomachs, known as gastric organoids, respond to infection very much like ordinary human stomachs.

There hasnt been any good way to study human stomach disease before because animals just dont get the same diseases, said James Wells, director of the Pluripotent Stem Cell Facility, Cincinnati Childrens Hospital Medical Center, who led the research which is published in Nature.

Human gastric diseases are associated with chronic infection by the bacterium Helicobacter pylori. Half the worlds population is infected with the bug, which can be picked up from food. Although most people do not show symptoms, once the infection is present up to 20% of carriers will develop gastric ulcers during their lifetimes. Around 2% will develop stomach cancer.

In developing countries, where H. pylori infection is more prevalent, gastric cancers are the second leading cause of cancer-related deaths.

Having grown the mini-stomachs, the researchers then injected them with H. pylori. In animals, H. pylori has little effect and disease does not follow but in the gastric organoid, the invading bacteria behaved as if it were a real human stomach.

The bacteria began injecting their proteins into the surrounding cells, and started to multiply. This is the hallmark of infection, said Wells. We can now very effectively study the bacteria and how it generates diseases. This has never been possible before with human tissue in vitro.

This is not the first time that miniature organs have been grown from stem cells. In 2013, scientists grew miniature kidneys and successfully transplanted into a rat. Replacement windpipes, grown from stem cells on lab-made scaffolds, have also been grown and transplanted into patients.

More:
Scientists grow miniature human stomachs from stem cells

Posted in Stem Cells | Comments Off on Scientists grow miniature human stomachs from stem cells

Mini-Stomachs Let Scientists Study Ulcers in a Lab Dish

Posted: October 29, 2014 at 7:46 pm

Scientists have grown miniature stomachs in a lab dish using stem cells, and are already using them to study stomach cancer. They hope they can grow patches to fix ulcers, find new drugs to treat and even prevent stomach cancer, and perhaps even grow replacement stomachs some day.

They discovered that the bacteria that cause stomach cancer begin doing their dirty work almost immediately, attaching to the stomach lining and causing tumors to start growing in response. Helicobacter pylori causes many, if not most, cases of stomach cancer, which affects more than 22,000 Americans a year and kills half of them. Stomach cancer is a major killer globally, affecting close to a million people a year and killing more than 70 percent of them.

And the team grew their mini-stomachs using two different types of stem cells human embryonic stem cells, grown from very early human embryos, but also induced pluripotent stem cells or iPS cells, which are made by tricking bits of skin or other tissue into acting like a stem cell.

In our hands they worked exactly the same, James Wells of Cincinnati Childrens Hospital Medical Center, who led the research. Both were able to generate, in a petri dish, human stomach tissue.

Immunofluorescent image of human stomach tissue made using stem cells

Stem cells are the body's master cells. Embryonic stem cells and iPS cells are both pluripotent meaning they can give rise to any tissue in the body. They've been used to grow miniature human livers, retinas, brain tissue and have been injected into eyes to treat eye disease.

Growing anything close to a real stomach or even a patch for an ulcer is a long way off. The gastric organoids Wellss team made the name up are just about the size of a BB bullet.

Its not easy getting stem cells to do what you want them to do. Wells and his team, including graduate student Kyle McCracken, had to use various growth factors and chemicals, each introduced at precisely the right time, to coax the cells into becoming three-dimensional blobs of stomach tissue. The stomach is a complex organ, with layers of muscle cells, cells that make up the stomach lining and glands that secrete proteins and acid to digest food.

"The bacteria immediately know what to do and they behaved as if they were in the stomach.

But the process worked, and the mini-stomachs look just like stomach tissue, the team reports in this weeks issue of the journal Nature.

See the original post:
Mini-Stomachs Let Scientists Study Ulcers in a Lab Dish

Posted in Stem Cells | Comments Off on Mini-Stomachs Let Scientists Study Ulcers in a Lab Dish

Medical groups call for major stem cell investment from public, private sector

Posted: October 29, 2014 at 7:42 pm

OTTAWA - A coalition of Canadian stem cell advocates, researchers and charities is calling for $1.5 billion in private and public funding for stem cell therapy over the next 10 years.

The coalition's action plan is aimed at cementing Canada's reputation as a stem cell leader, one that uses stem cell science to reduce suffering and death from cardiovascular diseases, cancer, diabetes, vision loss, spinal cord injuries and other conditions.

James Price, the president and CEO of the Canadian Stem Cell Foundation, says the action plan could help millions of people with new, life-changing therapies.

The action plan's call for funding includes a $50 million scaled annual average commitment by the federal government.

The Centre for Commercialization of Regenerative Medicine estimates the action plan could also create more than 12,000 jobs due to the growth of existing companies and the development of new enterprises aimed at global markets.

Read this article:
Medical groups call for major stem cell investment from public, private sector

Posted in Cell Therapy | Comments Off on Medical groups call for major stem cell investment from public, private sector

Page 1,955«..1020..1,9541,9551,9561,957..1,9601,970..»